Discovers and develops human antibody therapeutics
Kymab has raised €98M across 3 funding rounds from 1 investor, most recently a Series B round in May 2015. Based in Cambridge, UK; founded 2009; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2015-05-01 | Series B | €45M | Woodford Investment Management | View deal → |
| 2014-05-01 | Series B | €29M | — | View deal → |
| 2010-07-01 | Series A | €25M | — | View deal → |
